Apollo Global Management Inc.’s head of private equity capital markets, Matthew Manin, has left the firm to pursue another ...

Geode Capital Management LLC grew its holdings in shares of Alto Neuroscience, Inc. (NYSE:ANRO – Free Report) by 148.7% in the 3rd quarter, HoldingsChannel.com reports.The firm owned 469,988 ...

Alto Neuroscience, Inc. (ANRO) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...

LOS ANGELES, CA / ACCESSWIRE / January 6, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Alto ...

MORRISTOWN, N.J., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company committed to revolutionizing the treatment of underserved mental health ...

LOS ANGELES, CA / ACCESSWIRE / January 5, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Alto ...

Firefly Neuroscience, Inc. (AIFF), a prepackaged software company trading on The Nasdaq Capital Market, has reported significant leadership changes amid challenging market conditions. According to ...

Firefly Neuroscience, Inc. (AIFF), a prepackaged software company trading on The Nasdaq Capital Market, has reported significant leadership changes amid challenging market conditions. According to ...

Patient Enrollment Ongoing in Phase 2 RECONNECT Trial of RE104 in Postpartum Depression (PPD); Topline Data Anticipated Mid-2025 Initiation of Phase 2 REKINDLE Trial of RE104 in Adjustment ...

About Reunion Neuroscience Inc. Reunion Neuroscience is a clinical-stage biopharmaceutical company committed to revolutionizing the treatment of underserved mental health disorders through the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

today congratulates its partner Aspen Neuroscience, Inc. on use of the ClearPoint Neuro Navigation System to transplant dopaminergic neuron pr Aspen Neuroscience, Inc. announced today that it is ...